尚荣医疗收盘下跌1.30%，滚动市盈率143.67倍，总市值32.13亿元

Core Insights - The company, Shangrong Medical, closed at 3.8 yuan on July 29, with a decline of 1.30%, resulting in a rolling PE ratio of 143.67 times and a total market capitalization of 3.213 billion yuan [1] - The average PE ratio in the medical device industry is 55.46 times, with a median of 37.74 times, placing Shangrong Medical at the 109th position in the industry ranking [1] - As of March 31, 2025, the number of shareholders in Shangrong Medical is 58,323, a decrease of 621 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Company Overview - Shangrong Medical specializes in the production and sales of medical products, medical services, and health industry operations [1] - The company is recognized as one of the earliest to introduce clean technology into hospital operating rooms in China, with its intelligent self-controlled operating room products awarded national honors [1] - Shangrong Medical is classified as a national high-tech enterprise and has received over 180 patents, which serve as a driving force for its continuous development [1] Financial Performance - In the first quarter of 2025, the company reported an operating income of 280 million yuan, reflecting a year-on-year increase of 1.30%, and a net profit of 13.9642 million yuan, with a year-on-year growth of 0.58% [2] - The sales gross margin for the company stands at 15.27% [2] - The company's PE ratios are significantly higher than the industry averages, indicating a premium valuation compared to peers [2]